Basics Fulcrum Therapeutics, Inc. IPO Date: July 15, 2019 Sector: Healthcare Industry: Biotech Market Cap: $414.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.95% Avg Daily Range (30 D): $0.18 | 2.61% Avg Daily Range (90 D): $0.21 | 3.40% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 105 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 639 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $1.62M Avg Inst. Trade (90 D): $1.3M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $1.13M Avg Closing Volume: 180.43K     News Feb 7, 2025 @ 9:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: N/A Nov 6, 2024 @ 1:00 PM Fulcrum Therapeutics to Host Third Quarter 2024 Fi... Source: N/A Oct 11, 2024 @ 8:30 PM Fulcrum Therapeutics Reports Inducement Grants Und... Source: N/A Sep 24, 2024 @ 7:08 PM BHVN Stock Up as Rare Neurological Disease Study M... Source: Zacks Sep 19, 2024 @ 8:00 PM FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossm... Source: Bronstein, Gewirtz & Grossman, Llc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.18 $-.28 $-.28 Diluted EPS $-1.18 $-.28 $-.28 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -73.22M $ -17.3M $ -17.66M Operating Income / Loss $ -84.77M $ -19.82M $ -20.4M Cost of Revenue $ $ $ Net Cash Flow $ -44.13M $ -15.62M $ M PE Ratio